...
机译:使用基于生理学的药代动力学模型定量预测乳腺癌耐药蛋白介导的药物相互作用
Pfizer Inc;
Pfizer Inc;
Pfizer IncPfizer IncPharmaceut Co Johnson & Johnson;
ANION-TRANSPORTING POLYPEPTIDE; IN-VIVO EXTRAPOLATION; ROSUVASTATIN; CLEARANCE; DISPOSITION; INHIBITION; ABCG2; VARIABILITY; DISCOVERY; SUBSTRATE;
机译:Physiologically-Based Pharmacokinetic Models of CYP2D6 Substrate and Inhibitors Nebivolol, Cinacalcet and Mirabegron to Simulate Drug-Drug Interactions
机译:Physiologically-Based Pharmacokinetic Models of CYP2D6 Substrate and Inhibitors Nebivolol, Cinacalcet and Mirabegron to Simulate Drug-Drug Interactions
机译:Evaluation of Clinically Relevant Drug-Drug Interactions and Population Pharmacokinetics of Darolutamide in Patients with Nonmetastatic Castration-Resistant Prostate Cancer: Results of Pre-Specified and Post Hoc Analyses of the Phase III ARAMIS Trial
机译:CDO1 promoter methylation is a Biomarker for Outcome prediction of anthracycline Treated, Estrogen Receptor-positive, Lymph Node-positive Breast Cancer patients